| Vol. 15.32 – 26 August, 2020 |
| |
|
|
| Researchers applied crosslinking assisted proximity capture (CAP-C) to formaldehyde prefixed mouse ESCs and investigated loop domains and nonloop domains. They showed that CAP-C could be used to detect native chromatin conformation without formaldehyde prefixing. [Nature Biotechnology] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists define the translational landscape in leucine-rich repeat kinase 2 (LRRK2)-mutant dopaminergic neurons derived from human iPSCs via ribosome profiling. [Cell Stem Cell] |
|
|
|
| Investigators highlighted Glis1 as a powerful reprogramming factor, and revealed an epigenome–metabolome–epigenome signaling cascade that involved the glycolysis-driven coordination of histone acetylation and lactylation in the context of cell fate determination. [Nature Metabolism] |
|
|
|
| To understand the role of IMPA1 deficiency in intellectual disability, scientists generated iPSCs from patients and neurotypical controls and differentiated these into hippocampal dentate gyrus-like neurons and astrocytes. [Molecular Psychiatry] |
|
|
|
| Investigators used a published sequence of growth factors and drugs to induce mouse ESCs to differentiate into ureteric bud tissue. They characterized isolated engineered ureteric buds differentiated from ESCs in 3D culture and grafted them into ex fetu mouse kidney rudiments. [Journal of the American Society of Nephrology] |
|
|
|
| The authors provide a comprehensive resource for understanding human islet cell maturation and provides important insights into maturation of human pluripotent stem cells differentiated to insulin-secreting β cells (SC-β cells) and other SC-islet cell types to enable future differentiation strategy improvements. [Cell Reports] |
|
|
|
| β-Catenin is required to maintain ground state pluripotency in mouse ESCs, but its exact role is controversial. Researchers revealed a Tcf3-independent role of β-catenin in restraining germline and somatic lineage differentiation genes. They showed that β-catenin binds target genes with E2F6 and forms a complex with E2F6 and HMGA2 or E2F6 and HP1γ. [Stem Cell Reports] |
|
|
|
| Scientists generated a novel β-catenin knockout model in mouse ESCs (mESCs) to delete putatively functional N-terminally truncated isoforms observed in previous knockout models. They showed that aberrant N-terminally truncated isoforms are not functional in mESCs. [Stem Cell Reports] |
|
|
|
| The authors investigated cellular stress responses in human trisomy 21 and 13 neurons differentiated from patient-derived iPSCs. Their results suggested that aneuploidy-associated stress might be a therapeutic target for the neurodegenerative phenotypes in Down syndrome. [Scientific Reports] |
|
|
|
| To investigate how the combination of CSF3 therapy and CSF3R and RUNX1 mutations contributes to acute myeloid leukemia (AML) development, researchers made use of mouse models, severe congenital neutropenia (SCN)-derived iPSCs, and SCN and SCN-AML patient samples. [Cell Reports Medicine] |
|
|
|
|
| The authors present the disease and treatment concepts gathered using selected lysosomal storage diseases (LSD)-iPSCs, discuss iPSC research limitations, and set future research visions. [Molecular and Cellular Neuroscience] |
|
|
|
|
| Cytovia Therapeutics, has announced the filing of a provisional patent application with the US Patent & Trademark Office for the differentiation of natural killer (NK) cells from iPSCs. The NYSCF Research Institute is a pioneer and acknowledged leader in stem cell technology, having developed the premier automated robotic platform for reprogramming skin or blood into iPSCs and differentiating them into disease-relevant cell types. [Cytovia Therapeutics (GlobeNewswire, Inc.)] |
|
|
|
|
|
|
|
| Columbia University – New York City, New York, United States |
|
|
|
| Karolinska Institutet – Huddinge, Sweden |
|
|
|
| Memorial Sloan Kettering Cancer Center – New York City, New York, United States |
|
|
|
| Heidelberg Institute for Stem Cell Technologies and Experimental Medicine – Heidelberg, Baden-Württemberg, Germany |
|
|
|
| Icahn School of Medicine at Mount Sinai – New York City, New York, United States |
|
|
|
| University of Miami Health System – Miami, Florida, United States |
|
|
|
|